All lobbying filings

Horizon Blue Cross Blue Shield of New Jersey

Horizon Blue Cross Blue Shield of New Jersey filed a Q1 report for Horizon Blue Cross Blue Shield of New Jersey on April 20, 2026.

Lobbying for Horizon Blue Cross Blue Shield of New Jersey

As filed: HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY for HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY.

All filings by Horizon Blue Cross Blue Shield of New Jersey · Everything Horizon Blue Cross Blue Shield of New Jersey has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Expenses

$40,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

New Jersey

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

Affordable Care Act (ACA), ACA subsidies and tax credits; Telehealth/ telehealth flexibility; Rural healthcare; Marketplace Renewal Notices; Surprise Billing; Prior Authorization; Managed Care Organizations; Maternal Health; Hospital billing; Individual Market Reforms and eAPTC Extension; Healthcare Affordability. H.R.1909 - Preventing Maternal Deaths Reauthorization Act of 2025 To amend the Public Health Service Act to reauthorize support for State-based maternal mortality review committees, to direct the Secretary of Health and Human Services to disseminate best practices on maternal mortality prevention to hospitals, State-based professional societies, and perinatal quality collaboratives, and for other purposes. Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1] (Introduced 03/06/2025) H.R.1627 - TREATS Act To amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment, and for other purposes. Sponsor: Rep. Norcross, Donald [D-NJ-1]

Medicare/Medicaid

Medicare Advantage; Medicare/Transparency; Medicaid Cuts; Medicare Advantage & MA Rate Notice; Youth Mental Health; community engagement implementation; Site neutral payment reform. H.R.4077 - GUARD Veterans Health Care Act To amend title 38, United States Code, and the Social Security Act to permit recovery from the Department of Veterans Affairs of costs from Medicare Advantage and Medicare prescription drug plans and to modify the authority for recovery by the United States of reasonable charges for certain care or services furnished to veterans for non-service-connected disabilities, and for other purposes. Sponsor: Rep. Doggett, Lloyd [D-TX-37] S.1105 - No UPCODE Act To amend title XVIII of the Social Security Act to improve risk adjustment under Medicare Advantage. Sponsor: Sen. Cassidy, Bill [R-LA]

Pharmacy

Generics access; Prescription Drug Cost; Step Therapy H.R.1843 - Increasing Transparency in Generic Drug Applications Act To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2]

Bills named in this filing 5

H.R. 1909
Preventing Maternal Deaths Reauthorization Act of 2025
H.R. 1627
TREATS Act
H.R. 4077
GUARD Veterans’ Health Care Act
S. 1105
No UPCODE Act
H.R. 1843
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.